Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-06-26 | Mr. Smith holds a BSc in Chemistry and Biology and an HBSc in Pharmacology and Toxicology from the University of Western Ontario and a Masters in International Management from the American Graduate School of International Management in Arizona. Based on Mr. Smith’s extensive management experience in the pharmaceutical industry, our Board believes that Mr. Smith has the appropriate set of skills to serve as a member of the Board. |
| 2018-07-02 | Mr. Smith holds a BSc in Chemistry and Biology and an HBSc in Pharmacology and Toxicology from the University of Western Ontario and a Masters in International Management from the American Graduate School of International Management in Arizona. Based on Mr. Smith’s extensive management experience in the pharmaceutical industry, our Board believes that Mr. Smith has the appropriate set of skills to serve as a member of the Board. |
| 2018-12-20 | Scott A. Smith(7) Fees Earned or Paid in Cash ($) 52,500 ... The aggregate number of option awards held at December 19, 2018 was 15,000. |
| 2019-11-20 | Mr. Smith holds a BSc in Chemistry and Biology and an HBSc in Pharmacology and Toxicology from the University of Western Ontario and a Masters in International Management from the American Graduate School of International Management in Arizona. Based on Mr. Smith’s extensive management experience in the pharmaceutical industry, our Board believes that Mr. Smith has the appropriate set of skills to serve as a member of the Board. |
| 2020-01-31 | Scott A. Smith(6) - Represents shares issuable upon exercise of outstanding options. |
| 2020-05-22 | Scott A. Smith(9) - Represents shares issuable upon exercise of outstanding options. |
| 2020-11-02 | Scott A. Smith |
Data sourced from SEC filings. Last updated: 2025-10-11